Mustang Bio
MBIO
55 hedge funds and large institutions have $35.3M invested in Mustang Bio in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 14 reducing their positions, and 6 closing their positions.
308% more call options, than puts
Call options by funds: $326K | Put options by funds: $80K
29% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 14
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
0% more funds holding
Funds holding: 55 → 55 (0)
0% less ownership
Funds ownership: 0.04% → 0.04% (-0%)
12% less capital invested
Capital invested by funds: $40.1M → $35.3M (-$4.75M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$591K |
| 2 |
State Street
Boston,
Massachusetts
|
+$580K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$328K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$276K |
| 5 |
BlackRock
New York
|
+$178K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$875K |
| 2 |
CCM
Consonance Capital Management
New York
|
-$785K |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$610K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$367K |
| 5 |
Jane Street
New York
|
-$117K |
MBIO Hedge Fund Activity: Q3 2019 in Review
55 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q3 2019, worth a combined $35.3M — down 12% from $40.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new MBIO positions and 6 closed out — a net gain of 1 holder — while 18 added to existing stakes and 14 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $591K. The largest seller was Vanguard Group, cutting an estimated $875K.
- 55 institutional investors held Mustang Bio (MBIO) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $35.3M of Mustang Bio stock for Q3 2019, down 12% quarter-over-quarter.
- 7 funds opened new Mustang Bio positions in Q3 2019 and 6 closed out, a net change of +1 holder.
- The largest Mustang Bio buyer in Q3 2019 was Renaissance Technologies, an estimated $591K added.
- The largest Mustang Bio seller in Q3 2019 was Vanguard Group, an estimated $875K sold.
Based on aggregated 13F filings for Q3 2019.